4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-23-001007
Options or other derivatives
- Director acquired 48,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Fraser Claire · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-04 | Grant or award : show line 1 in the form Stock Option (right to buy) | +48,000 | 48,000 | D |
Loading xslF345X03/doc4.xml…